Latest news
Why Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:50:32 GMTTarsus Pharmaceuticals (TARS) Stock Can Revenue Momentum Outrun Rising Costs - simplywall.stsimplywall.st · Sat, 08 Aug 2026 01:11:15 GMTTarsus Pharmaceuticals 2026 Q2 Results: XDEMVY Sales, Risks, and Key Financials Revealed - MinichartMinichart · Fri, 07 Aug 2026 00:02:00 GMTTarsus Pharmaceuticals Inc (TARS) (Q2 2026) Earnings Call Highlights: Record XDEMVY Sales and ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 19:02:11 GMTTarsus Pharmaceuticals Raises 2026 XDEMVY Net Pdt Sales Guidance to $685M-$705M >TARS - MoomooMoomoo · Thu, 06 Aug 2026 18:00:39 GMTTarsus Pharmaceuticals Q2 sales beat estimates, lifts 2026 XDEMVY sales outlook - TradingViewTradingView · Thu, 06 Aug 2026 11:36:49 GMT